Envoy Medical, Inc. (COCH)

Market Cap	27.76M
Revenue (ttm)	222,000
Net Income (ttm)	-28.20M
Shares Out	21.52M
EPS (ttm)	-1.40
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60,174
Open	1.280
Previous Close	1.330
Day's Range	1.280 - 1.300
52-Week Range	1.060 - 3.990
Beta	2.18
Analysts	Strong Buy
Price Target	9.25 (+611.54%)
Earnings Date	Nov 13, 2025

About COCH

Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 42
• Stock Exchange: NASDAQ
• Ticker Symbol: COCH
• Website: https://www.envoymedical.com

Financial Performance

In 2024, Envoy Medical's revenue was $225,000, a decrease of -28.80% compared to the previous year's $316,000. Losses were -$27.97 million, -10.55% less than in 2023.

Analyst Summary

According to 2 analysts, the average rating for COCH stock is "Strong Buy." The 12-month stock price target is $9.25, which is an increase of 611.54% from the latest price.

Price Target

$9.25

(611.54% upside)

Analyst Consensus: Strong Buy